Mirna Chehade

803 total citations
23 papers, 180 citations indexed

About

Mirna Chehade is a scholar working on Surgery, Immunology and Rheumatology. According to data from OpenAlex, Mirna Chehade has authored 23 papers receiving a total of 180 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 6 papers in Immunology and 5 papers in Rheumatology. Recurrent topics in Mirna Chehade's work include Eosinophilic Esophagitis (19 papers), Eosinophilic Disorders and Syndromes (5 papers) and IL-33, ST2, and ILC Pathways (4 papers). Mirna Chehade is often cited by papers focused on Eosinophilic Esophagitis (19 papers), Eosinophilic Disorders and Syndromes (5 papers) and IL-33, ST2, and ILC Pathways (4 papers). Mirna Chehade collaborates with scholars based in United States, Netherlands and Spain. Mirna Chehade's co-authors include Rosan Meyer, Jonathan M. Spergel, Evan S. Dellon, Eilish McCann, Jennifer D. Hamilton, Elizabeth Laws, Leda Mannent, Arsalan Shabbir, Lila Glotfelty and Albert J. Bredenoord and has published in prestigious journals such as Gastroenterology, Journal of Allergy and Clinical Immunology and The American Journal of Gastroenterology.

In The Last Decade

Mirna Chehade

20 papers receiving 180 citations

Peers

Mirna Chehade
Agurtzane Bilbao Spain
Chien‐Chia Chuang United States
Rosa Jiménez‐Feijoo Spain
R. M. Berdondini Italy
Emily Boozalis United States
E. Galliani Italy
Jørgen Guldberg–Møller Denmark
Angela L. Bosma Netherlands
Walter Scordo Argentina
Ki-Won Nam United States
Agurtzane Bilbao Spain
Mirna Chehade
Citations per year, relative to Mirna Chehade Mirna Chehade (= 1×) peers Agurtzane Bilbao

Countries citing papers authored by Mirna Chehade

Since Specialization
Citations

This map shows the geographic impact of Mirna Chehade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirna Chehade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirna Chehade more than expected).

Fields of papers citing papers by Mirna Chehade

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mirna Chehade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirna Chehade. The network helps show where Mirna Chehade may publish in the future.

Co-authorship network of co-authors of Mirna Chehade

This figure shows the co-authorship network connecting the top 25 collaborators of Mirna Chehade. A scholar is included among the top collaborators of Mirna Chehade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirna Chehade. Mirna Chehade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Dellon, Evan S., Mirna Chehade, Nirmala Gonsalves, et al.. (2025). Sa1277: DUPILUMAB IMPROVES EDEMA, RINGS, EXUDATES, FURROWS, AND STRICTURES ON ENDOSCOPY: POOLED ANALYSIS FROM TWO PHASE 3 STUDIES (EOE KIDS AND LIBERTY EOE TREET). Gastroenterology. 169(1). S–428. 1 indexed citations
3.
Chehade, Mirna, et al.. (2025). Economic Burden and Health Care Resource Utilization of Patients With Eosinophilic Esophagitis in the United States. Journal of Clinical Gastroenterology. 1 indexed citations
4.
Chehade, Mirna, Evan S. Dellon, Jonathan M. Spergel, et al.. (2024). Dupilumab Improves Histologic And Endoscopic Outcomes In Children Aged 1 To <12 Years With Eosinophilic Esophagitis (EoE): 52-Week Results From The Phase 3 EoE KIDS Trial. Journal of Allergy and Clinical Immunology. 153(2). AB266–AB266. 3 indexed citations
5.
Dellon, Evan S., Marc E. Rothenberg, Mirna Chehade, et al.. (2024). A Phase 2/3 Study To Assess The Efficacy And Safety Of Dupilumab Versus Placebo In Adults And Adolescents With Eosinophilic Gastritis With Or Without Eosinophilic Duodenitis. Journal of Allergy and Clinical Immunology. 153(2). AB201–AB201.
6.
Chehade, Mirna, Evan S. Dellon, Jonathan M. Spergel, et al.. (2023). 605 DUPILUMAB IMPROVES HISTOLOGIC AND ENDOSCOPIC ASPECTS OF EOSINOPHILIC ESOPHAGITIS IN CHILDREN AGED 1-11 YEARS IN THE PHASE 3 EOE KIDS TRIAL. Gastroenterology. 164(6). S–112. 1 indexed citations
7.
Rothenberg, Marc E., Evan S. Dellon, Margaret H. Collins, et al.. (2023). Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. ˜The œLancet. Gastroenterology & hepatology. 8(11). 990–1004. 53 indexed citations
8.
McCann, Eilish, Mirna Chehade, Jonathan M. Spergel, et al.. (2023). Validation of the novel Eosinophilic Esophagitis Impact Questionnaire. Journal of Patient-Reported Outcomes. 7(1). 120–120. 4 indexed citations
9.
Rothenberg, Marc E., Evan S. Dellon, Albert J. Bredenoord, et al.. (2022). Dupilumab Improves Clinical and Histologic Aspects of Disease in Adult and Adolescent Patients With Eosinophilic Esophagitis at Week 24: Results from Part B of the 3-Part LIBERTY EoE TREET Study. Journal of Allergy and Clinical Immunology. 149(2). AB312–AB312. 7 indexed citations
10.
Chehade, Mirna, et al.. (2022). S393 Health Care Resource Utilization and Costs Among Eosinophilic Esophagitis Patients in the United States. The American Journal of Gastroenterology. 117(10S). e274–e275. 1 indexed citations
11.
Dellon, Evan S., Marc E. Rothenberg, Ikuo Hirano, et al.. (2021). Dupilumab Improves Health-Related Quality of Life (HRQoL) and Reduces Symptom Burden in Patients with Eosinophilic Esophagitis (EoE): Results From Part A of a Randomized, Placebo-Controlled Three-Part Phase 3 Study. Journal of Allergy and Clinical Immunology. 147(2). AB91–AB91. 10 indexed citations
12.
Kamat, Siddhesh, Degang Wang, Urvi Mujumdar, et al.. (2021). S415 Increasing Prevalence of Eosinophilic Esophagitis in the United States from 2015 to 2018. The American Journal of Gastroenterology. 116(1). S184–S185. 2 indexed citations
13.
Chehade, Mirna, et al.. (2019). Feeding difficulties in children with non–IgE-mediated food allergic gastrointestinal disorders. Annals of Allergy Asthma & Immunology. 122(6). 603–609. 40 indexed citations
14.
15.
Sand, Ilana Katz, Michelle Fabian, Russell Telford, et al.. (2018). Open-label, add-on trial of cetirizine for neuromyelitis optica. Neurology Neuroimmunology & Neuroinflammation. 5(2). e441–e441. 23 indexed citations
16.
Leonard, Stephanie A. & Mirna Chehade. (2017). Food Protein-Induced Enterocolitis Syndrome. The Journal of Allergy and Clinical Immunology In Practice. 5(2). 525–526. 3 indexed citations
17.
Lieberman, Phil, et al.. (2012). Dietary Therapy and Topical Corticosteroids Can Reverse Esophageal Fibrosis in Patients with Eosinophilic Esophagitis. Journal of Allergy and Clinical Immunology. 129(2). AB246–AB246. 1 indexed citations
18.
Chehade, Mirna, et al.. (2004). De Novo Food Allergy After Intestinal Transplantation: A Report of Three Cases. Journal of Pediatric Gastroenterology and Nutrition. 38(5). 545–547. 1 indexed citations
19.
Chehade, Mirna, et al.. (2004). De Novo Food Allergy After Intestinal Transplantation: A Report of Three Cases. Journal of Pediatric Gastroenterology and Nutrition. 38(5). 545–547. 18 indexed citations
20.
Braegger, Christian, Mirna Chehade, & Keith Benkov. (2001). A Multicenter Trial of 6-Mercaptopurine and Prednisone in Children With Newly Diagnosed Crohn Disease. Journal of Pediatric Gastroenterology and Nutrition. 32(2). 120–121. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Agurtzane Bilbao Breakdown of academic impact, for papers by Chien‐Chia Chuang Breakdown of academic impact, for papers by Rosa Jiménez‐Feijoo Breakdown of academic impact, for papers by R. M. Berdondini Breakdown of academic impact, for papers by Emily Boozalis Breakdown of academic impact, for papers by E. Galliani Breakdown of academic impact, for papers by Jørgen Guldberg–Møller Breakdown of academic impact, for papers by Angela L. Bosma Breakdown of academic impact, for papers by Walter Scordo Breakdown of academic impact, for papers by Ki-Won Nam
Rankless by CCL
2026